268 related articles for article (PubMed ID: 28076901)
1. Nuclear factor one transcription factors as epigenetic regulators in cancer.
Fane M; Harris L; Smith AG; Piper M
Int J Cancer; 2017 Jun; 140(12):2634-2641. PubMed ID: 28076901
[TBL] [Abstract][Full Text] [Related]
2. The convergent roles of the nuclear factor I transcription factors in development and cancer.
Chen KS; Lim JWC; Richards LJ; Bunt J
Cancer Lett; 2017 Dec; 410():124-138. PubMed ID: 28962832
[TBL] [Abstract][Full Text] [Related]
3. Intra-tumour heterogeneity - going beyond genetics.
Caiado F; Silva-Santos B; Norell H
FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
[TBL] [Abstract][Full Text] [Related]
4. Understanding the epigenetic regulation of tumours and their microenvironments: opportunities and problems for epigenetic therapy.
Liu M; Zhou J; Chen Z; Cheng AS
J Pathol; 2017 Jan; 241(1):10-24. PubMed ID: 27770445
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic control of cellular senescence in disease: opportunities for therapeutic intervention.
Atkinson SP; Keith WN
Expert Rev Mol Med; 2007 Mar; 9(7):1-26. PubMed ID: 17352843
[TBL] [Abstract][Full Text] [Related]
6. Intra-tumor heterogeneity from a cancer stem cell perspective.
Prasetyanti PR; Medema JP
Mol Cancer; 2017 Feb; 16(1):41. PubMed ID: 28209166
[TBL] [Abstract][Full Text] [Related]
7. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
8. Early epigenetic cancer decisions.
Martín-Lorenzo A; Gonzalez-Herrero I; Rodríguez-Hernández G; García-Ramírez I; Vicente-Dueñas C; Sánchez-García I
Biol Chem; 2014 Nov; 395(11):1315-20. PubMed ID: 25205718
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic regulation of cancer stem cell gene expression.
Bapat SA
Subcell Biochem; 2013; 61():419-34. PubMed ID: 23150261
[TBL] [Abstract][Full Text] [Related]
10. A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha.
Seidel S; Garvalov BK; Wirta V; von Stechow L; Schänzer A; Meletis K; Wolter M; Sommerlad D; Henze AT; Nistér M; Reifenberger G; Lundeberg J; Frisén J; Acker T
Brain; 2010 Apr; 133(Pt 4):983-95. PubMed ID: 20375133
[TBL] [Abstract][Full Text] [Related]
11. [Cancer stem cells as a possible source of tumor initiation and progression].
Puchinskaya MV
Vopr Onkol; 2016; 62(1):14-23. PubMed ID: 30444327
[TBL] [Abstract][Full Text] [Related]
12. HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression.
Philip B; Ito K; Moreno-Sánchez R; Ralph SJ
Carcinogenesis; 2013 Aug; 34(8):1699-707. PubMed ID: 23740838
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor one transcription factors: Divergent functions in developmental versus adult stem cell populations.
Harris L; Genovesi LA; Gronostajski RM; Wainwright BJ; Piper M
Dev Dyn; 2015 Mar; 244(3):227-38. PubMed ID: 25156673
[TBL] [Abstract][Full Text] [Related]
14. Chromatin accessibility contributes to simultaneous mutations of cancer genes.
Shi Y; Su XB; He KY; Wu BH; Zhang BY; Han ZG
Sci Rep; 2016 Oct; 6():35270. PubMed ID: 27762310
[TBL] [Abstract][Full Text] [Related]
15. Inflammation and cancer stem cells.
Shigdar S; Li Y; Bhattacharya S; O'Connor M; Pu C; Lin J; Wang T; Xiang D; Kong L; Wei MQ; Zhu Y; Zhou S; Duan W
Cancer Lett; 2014 Apr; 345(2):271-8. PubMed ID: 23941828
[TBL] [Abstract][Full Text] [Related]
16. The complexity of epigenetic diseases.
Brazel AJ; Vernimmen D
J Pathol; 2016 Jan; 238(2):333-44. PubMed ID: 26419725
[TBL] [Abstract][Full Text] [Related]
17. Analysis of microRNA expression in canine mammary cancer stem-like cells indicates epigenetic regulation of transforming growth factor-beta signaling.
Rybicka A; Mucha J; Majchrzak K; Taciak B; Hellmen E; Motyl T; Krol M
J Physiol Pharmacol; 2015 Feb; 66(1):29-37. PubMed ID: 25716962
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer.
Lee HK; Lee DS; Park JC
BMC Cancer; 2015 Mar; 15():113. PubMed ID: 25879941
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
20. [Epigenetic processes in malignant transformation: the role of DNA methylation in cancer development].
Suijkerbuijk KP; van der Wall E; van Laar T; Vooijs M; van Diest PJ
Ned Tijdschr Geneeskd; 2007 Apr; 151(16):907-13. PubMed ID: 17500342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]